Clinical Trials
253 trialsTERMOMIRNA
IRCCS Azienda Ospedaliero-Universitaria di Bologna
A Subharmonic-Aided Pressure Estimate Technology for Prediction of Response to Systemic Therapy in Gastric Cancer Liver Metastases
The First Hospital of Jilin University
ROCK-RT
University of Sydney
LEARN
University of Sydney
OvAR-Y
Washington University School of Medicine
Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment
Tongji Hospital
CIRT-FR
Cardiovascular and Interventional Radiological Society of Europe
4D-MRI for Precision Medicine
University of Virginia
iCaRe2
University of Nebraska
Extracellular RNA Markers of Liver Disease and Cancer
Mayo Clinic
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
University of Missouri-Columbia
BILIVER
Azienda USL Toscana Centro
CER
Cancer Support Community, Research and Training Institute, Philadelphia
Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
Stanford University
Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease
Nanfang Hospital, Southern Medical University
ELUCIDATE
City of Hope Medical Center
VOCAL
Imperial College London
Optimizing Y90 Therapy for Radiation Lobectomy
Northwestern University
(CLOCS-2)
Imperial College London
Treat Primary and Metastatic Liver Tumors
Methodist Health System
QUS in HCC
Centre hospitalier de l'Université de Montréal (CHUM)
EXOMIC
City of Hope Medical Center
LUMIC
City of Hope Medical Center
MR Guidance for Liver and Pancreas
University Health Network, Toronto
MOMENTUM
UMC Utrecht
Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
M.D. Anderson Cancer Center
Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection
West China Hospital
I-GROWtoh
IRCCS Azienda Ospedaliero-Universitaria di Bologna
MICRO-VAR
Central Hospital, Nancy, France
Biobank for Cholestatic Liver Diseases.
Mayo Clinic
BLOOD-TACE-M
University of Belgrade
PLATON
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
BLOOD-TACE-P
University of Belgrade
GENDER-HCC-MET
Tongji University
Breath Analysis Based Disease Biomarkers
Mayo Clinic
RASEREM
Ankara University
Radiotherapy Safety for Liver Malignancies Using Post-Treatment Imaging
The Third Xiangya Hospital of Central South University
Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
Memorial Sloan Kettering Cancer Center
Prediction Model for MINS After Major Hepatobiliary Surgery
Beijing Tsinghua Chang Gung Hospital
Liver and Biliary Tumor Tissue Registry
Mayo Clinic
Impact of Emotional Disorders on Response to Immune Checkpoint Inhibitor Therapy in Liver Cancer
Tongji Hospital
Effect of TCC Cocktail Combined With TACE Versus TACE Alone on Survival in uHCC Patients
Shanghai Zhongshan Hospital
An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver Cancer
University Hospital, Ghent
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
Palo Alto Veterans Institute for Research
Diagnostic Accuracy of Folate-Targeted NIR-II Carbon Dots for Ex Vivo HCC Detection
West China Hospital
CENTINEL
City of Hope Medical Center
Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy
Konkuk University Medical Center
DTECT-Liver
Johns Hopkins University
The Study Collect Clinical Data From the Treatment of Liver Cancer With New Drugs After 2019 and Integrate Biochemical and Pathological Indicators to Analyze Prognostic Outcomes, Including Overall Survival, Progression-free Survival, and Complications.
National Taiwan University Hospital
Registry to Collect Health Information Related to Fibrolamellar Cancer
Memorial Sloan Kettering Cancer Center